Redox-driven speciation and colloid formation contribute the in vivo chemistry and organ deposition of Astatine-211
{{output}}
Background: Astatine-211 (211At) is a promising radionuclide for targeted alpha therapy (TAT), yet its clinical translation is hindered by poor in vivo stability and pronounced non-target organ accumulation. The fundamental radio... ...
